title: Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).
abstract: Women are at higher risk than men for bleeding and vascular complications after percutaneous coronary intervention (PCI). Compared with femoral access, radial access reduces these complications but may be more challenging in women because of higher rates of radial artery spasm, tortuosity, and occlusion as well as lower rates of procedure success. Whether the safety advantages of radial versus femoral access in women undergoing PCI are outweighed by reduced effectiveness has not been studied. The Study of Access site For Enhancement of PCI for Women is a prospective, randomized clinical trial comparing radial with femoral arterial access in women undergoing PCI. In conjunction with the US Food and Drug Administration's Critical Path Cardiac Safety Research Consortium, this study embeds the randomized clinical trial into the existing infrastructure of the National Cardiovascular Data Registry CathPCI Registry through the National Institute of Health's National Cardiovascular Research Infrastructure. The primary efficacy end point is a composite of bleeding (Bleeding Academic Research Consortium types 2, 3, or 5) or vascular complication requiring intervention occurring at 72 hours after PCI or by hospital discharge. The primary feasibility end point is procedure success. Secondary end points include procedure duration, contrast volume, radiation dose, quality of life, and a composite of 30-day death, vascular complication, or unplanned revascularization.
authors.affiliation: Duke Clinical Research Institute, Durham, NC.
authors.forename: Connie N
authors.initials: CN
authors.lastname: Hess
authors.forename: Sunil V
authors.initials: SV
authors.lastname: Rao
authors.forename: David F
authors.initials: DF
authors.lastname: Kong
authors.forename: Laura H
authors.initials: LH
authors.lastname: Aberle
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Anstrom
authors.forename: C Michael
authors.initials: CM
authors.lastname: Gibson
authors.forename: Ian C
authors.initials: IC
authors.lastname: Gilchrist
authors.forename: Alice K
authors.initials: AK
authors.lastname: Jacobs
authors.forename: Sanjit S
authors.initials: SS
authors.lastname: Jolly
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: John C
authors.initials: JC
authors.lastname: Messenger
authors.forename: L Kristin
authors.initials: LK
authors.lastname: Newby
authors.forename: Ron
authors.initials: R
authors.lastname: Waksman
authors.forename: Mitchell W
authors.initials: MW
authors.lastname: Krucoff
mesh_terms: D005260:Female; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000379:methods*; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D011446:Prospective Studies; D011788:Quality of Life; D017534:Radial Artery / Q000601:surgery*; D012042:Registries; D016896:Treatment Outcome
references.citation: Am Heart J. 2013 Mar;165(3):344-53.e1
references.pmid: 23453103
references.citation: Am J Cardiol. 2003 Oct 15;92(8):930-5
references.pmid: 14556868
references.citation: Lancet. 2011 Apr 23;377(9775):1409-20
references.pmid: 21470671
references.citation: Heart. 2008 Aug;94(8):1019-25
references.pmid: 18332059
references.citation: J Am Coll Cardiol. 2013 May 21;61(20):2070-8
references.pmid: 23524046
references.citation: Circ Cardiovasc Interv. 2009 Oct;2(5):423-9
references.pmid: 20031752
references.citation: Circulation. 1987 Jul;76(1):142-54
references.pmid: 3109764
references.citation: JACC Cardiovasc Interv. 2008 Apr;1(2):202-9
references.pmid: 19463301
references.citation: Am Heart J. 2009 Apr;157(4):740-5
references.pmid: 19332204
references.citation: Circulation. 2013 Jun 11;127(23):2295-306
references.pmid: 23753843
references.citation: JACC Cardiovasc Interv. 2011 Feb;4(2):191-7
references.pmid: 21349458
references.citation: Catheter Cardiovasc Interv. 2008 Sep 1;72(3):335-340
references.pmid: 18726956
references.citation: J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9
references.pmid: 22858390
references.citation: Circulation. 2011 Jun 14;123(23):2736-47
references.pmid: 21670242
references.citation: Catheter Cardiovasc Interv. 2013 Jan 1;81(1):34-9
references.pmid: 22431421
references.citation: Cathet Cardiovasc Diagn. 1997 Dec;42(4):467-8
references.pmid: 9408639
references.citation: JACC Cardiovasc Interv. 2008 Aug;1(4):379-86
references.pmid: 19463333
references.citation: J Am Coll Cardiol. 2007 Mar 27;49(12):1362-8
references.pmid: 17394970
references.citation: J Am Coll Cardiol. 2009 Jun 2;53(22):2019-27
references.pmid: 19477350
references.citation: Am Heart J. 2009 Jan;157(1):132-40
references.pmid: 19081409
references.citation: Circulation. 2006 Dec 12;114(24):2636-43
references.pmid: 17145988